Top Midday Decliners

MT Newswires Live

Jan 17, 2025

Atara Biotherapeutics (ATRA) reported "compliance issues" on Thursday involving a third-party manufacturing facility for Ebvallo, a treatment for patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease.

Shares slumped 37% as intraday trading volume catapulted to over 1.8 million million versus a daily average of about 127,000.

Silexion Therapeutics (SLXN) shares slumped intraday after the company overnight disclosed a $5 million equity offering to fund pre-clinical studies.

Shares plunged 42% as intraday trading volume rose to roughly 6.58 million from the stock's daily average of about 4.63 million.

US Bancorp (USB) shares dropped after the company reported Thursday Q4 revenue that missed expectations.

Shares slid 5%, with intraday trading volume at nearly 11.6 million versus the stock's daily average of over 7.61 million.

Price: 8.29, Change: -4.87, Percent Change: -37.00

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2504465109"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2504465109\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2504465109?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-17 02:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2504465109","market":"fut","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/ATRA\">Atara Biotherapeutics</a> (ATRA) reported \"compliance issues\" on Thursday involving a third-party manufacturing facility for Ebvallo, a treatment for patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease.</p><p>Shares slumped 37% as intraday trading volume catapulted to over 1.8 million million versus a daily average of about 127,000.</p><p>Silexion <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (SLXN) shares slumped intraday after the company overnight disclosed a $5 million equity offering to fund pre-clinical studies.</p><p>Shares plunged 42% as intraday trading volume rose to roughly 6.58 million from the stock's daily average of about 4.63 million.</p><p>US Bancorp (USB) shares dropped after the company reported Thursday Q4 revenue that missed expectations.</p><p>Shares slid 5%, with intraday trading volume at nearly 11.6 million versus the stock's daily average of over 7.61 million.</p><p>Price: 8.29, Change: -4.87, Percent Change: -37.00</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-17 02:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/ATRA\">Atara Biotherapeutics</a> (ATRA) reported \"compliance issues\" on Thursday involving a third-party manufacturing facility for Ebvallo, a treatment for patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease.</p><p>Shares slumped 37% as intraday trading volume catapulted to over 1.8 million million versus a daily average of about 127,000.</p><p>Silexion <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (SLXN) shares slumped intraday after the company overnight disclosed a $5 million equity offering to fund pre-clinical studies.</p><p>Shares plunged 42% as intraday trading volume rose to roughly 6.58 million from the stock's daily average of about 4.63 million.</p><p>US Bancorp (USB) shares dropped after the company reported Thursday Q4 revenue that missed expectations.</p><p>Shares slid 5%, with intraday trading volume at nearly 11.6 million versus the stock's daily average of over 7.61 million.</p><p>Price: 8.29, Change: -4.87, Percent Change: -37.00</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4207","symbol_name":"综合性银行","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2504465109","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2504465109","pubTimestamp":1737052299,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Atara Biotherapeutics (ATRA) reported \"compliance issues\" on Thursday involving a third-party manufacturing facility for Ebvallo, a treatment for patients with Epstein-Barr virus-positive post-transpl","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4207":"综合性银行","BK4559":"巴菲特持仓","USB":"美国合众银行","ATRA":"Atara Biotherapeutics","BK4588":"碎股","BK4585":"ETF&股票定投概念","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4139":"生物科技","SLXN":"Silexion Therapeutics Corp","BK4504":"桥水持仓","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"USB":0.9,"ATRA":0.9,"SLXN":0.9},"content_text":"Atara Biotherapeutics (ATRA) reported \"compliance issues\" on Thursday involving a third-party manufacturing facility for Ebvallo, a treatment for patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease.Shares slumped 37% as intraday trading volume catapulted to over 1.8 million million versus a daily average of about 127,000.Silexion Therapeutics (SLXN) shares slumped intraday after the company overnight disclosed a $5 million equity offering to fund pre-clinical studies.Shares plunged 42% as intraday trading volume rose to roughly 6.58 million from the stock's daily average of about 4.63 million.US Bancorp (USB) shares dropped after the company reported Thursday Q4 revenue that missed expectations.Shares slid 5%, with intraday trading volume at nearly 11.6 million versus the stock's daily average of over 7.61 million.Price: 8.29, Change: -4.87, Percent Change: -37.00","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}